MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis

MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis

Jian Zheng,1 Xiaoxi Li,2 Cunwei Cai,3 Chengyu Hong,1 Bin Zhang4 1Department of Thoracic Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Insititute, Shenyang, Liaoning, 110042, People’s Republic of China; 2Central Laboratory, Cancer Hospital of Chin...

Full description

Bibliographic Details
Main Authors: Zheng J, Li X, Cai C, Hong C, Zhang B
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:Cancer Management and Research
Subjects:
non-small cell lung cancer
mir-32
mir-548a
cisplatin resistance
robo1
wnt/β-catenin pathway
Online Access:https://www.dovepress.com/microrna-32-and-microrna-548a-promote-the-drug-sensitivity-of-non-smal-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/microrna-32-and-microrna-548a-promote-the-drug-sensitivity-of-non-smal-peer-reviewed-article-CMAR

Similar Items